Want to see IN:MAXHEALTH full AI Analyst Report?
MAXHEALTH Stock Chart & Stats
₹1202.35
₹4.85(0.40%)
At close: 4:00 PM EST
₹1202.35
₹4.85(0.40%)
Day’s Range― - ―
52-Week Range₹797.00 - ₹1,196.50
Previous CloseN/A
Volume2.66M
Average Volume (3M)722.55K
Market Cap
₹828.73B
Enterprise Value₹968.05B
Total Cash (Recent Filing)₹6.66B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)56.9
Beta1.01
Next Earnings
Oct 30, 2026EPS Estimate
4.31Next Dividend Ex-DateN/A
Dividend Yield0.23%
Share Statistics
EPS (TTM)14.97
Shares Outstanding973,310,240
10 Day Avg. Volume1,208,987
30 Day Avg. Volume722,546
Financial Highlights & Ratios
PEG Ratio1.90
Price to Book (P/B)8.67
Price to Sales (P/S)11.13
P/FCF Ratio626.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)18.82
Revenue Forecast (FY)₹119.93B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthRevenue has scaled meaningfully over several years and growth remained positive into 2026, indicating continued demand for the hospital network’s services. Sustained expansion can support operating leverage, broaden clinical reach, and strengthen reinvestment capacity.
Operating ProfitabilityStrong gross margins and sustained operating profitability show that the company converts its hospital platform and clinical mix into earnings. This provides internal capacity to fund service expansion and absorb moderate cost pressure, although recent trends require monitoring.
Equity BaseA large and growing equity base, together with improving returns on equity after the 2021 loss, supports financial resilience. This capital foundation can help the company invest in capacity and specialized care while maintaining a stronger base for long-term growth.
Bears Say
Sharp Debt IncreaseDebt increased sharply in 2026 after a very low-leverage profile in 2023–2024. The step-up reduces financial flexibility and makes the business more sensitive to refinancing conditions and interest costs, potentially constraining investment or shareholder returns.
Weak Free Cash FlowFree cash flow has been volatile, declining in 2024 and falling sharply again in 2026 versus 2025. Weaker cash generation can limit internally funded expansion and reduce resilience, even when accounting profits remain solid.
Margin And Profit PressureNet margin has declined from its 2023 peak, while 2026 operating profit was lower than in 2025. If sustained, this indicates pressure from costs or business mix and could limit earnings growth even as revenue continues to expand.
Max Healthcare Institute Ltd News
MAXHEALTH FAQ
What was Max Healthcare Institute Ltd’s price range in the past 12 months?
Max Healthcare Institute Ltd lowest stock price was ₹797.00 and its highest was ₹1196.50 in the past 12 months.
What is Max Healthcare Institute Ltd’s market cap?
Max Healthcare Institute Ltd’s market cap is ₹828.73B.
When is Max Healthcare Institute Ltd’s upcoming earnings report date?
Max Healthcare Institute Ltd’s upcoming earnings report date is Oct 30, 2026 which is today.
How were Max Healthcare Institute Ltd’s earnings last quarter?
Max Healthcare Institute Ltd released its earnings results on Aug 13, 2026. The company reported ₹3.7 earnings per share for the quarter, missing the consensus estimate of ₹4.073 by -₹0.373.
Is Max Healthcare Institute Ltd overvalued?
According to Wall Street analysts Max Healthcare Institute Ltd’s price is currently Overvalued.
Does Max Healthcare Institute Ltd pay dividends?
Max Healthcare Institute Ltd pays a Annually dividend of ₹2 which represents an annual dividend yield of 0.23%. See more information on Max Healthcare Institute Ltd dividends here
What is Max Healthcare Institute Ltd’s EPS estimate?
Max Healthcare Institute Ltd’s EPS estimate is 4.31.
How many shares outstanding does Max Healthcare Institute Ltd have?
Max Healthcare Institute Ltd has 973,310,240 shares outstanding.
What happened to Max Healthcare Institute Ltd’s price movement after its last earnings report?
Max Healthcare Institute Ltd reported an EPS of ₹3.7 in its last earnings report, missing expectations of ₹4.073. Following the earnings report the stock price went up 0.109%.
Which hedge fund is a major shareholder of Max Healthcare Institute Ltd?
Currently, no hedge funds are holding shares in IN:MAXHEALTH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Max Healthcare Institute Ltd
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, gynecology, pediatrics, and nephrology, liver and biliary sciences, gastroenterology and Gi surgery, plastic and reconstructive surgery, and organ transplants, as well as ear, nose, and throat. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres. The company was incorporated in 2001 and is based in Gurugram, India.
Technical Analysis
Apollo Hospitals Enterprise Limited
―
Aster DM Healthcare Ltd.
―
Fortis Healthcare Ltd.
―
Global Health Limited
―
Narayana Hrudayalaya Ltd.
―